Evolus, Inc. Cash Flow Statement
EOLS|7 years of annual SEC 10-K data (FY2019-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$34M
FY2025
Free Cash Flow
-$34M
FY2025
Capital Expenditures
$473,000
Cash used for long-term assets
Dividends Paid
N/A
FY2025
Evolus, Inc. used $34M in operating cash flow and negative free cash flow of $34M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- High leverage: Debt-to-equity ratio of 26.46
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income | -$61.7M | -$74.4M | -$74.4M | -$46.8M | -$163.0M | -$90.0M | -$46.9M |
| Depreciation & Amortization | $5.1M | $3.7M | $3.7M | $5.6M | $7.0M | $4.1M | $9.0K |
| Operating Cash Flow | -$34.0M | -$84.9M | -$84.9M | -$33.4M | -$57.9M | -$93.4M | -$25.7M |
| Capital Expenditures | $473.0K | $1.6M | $1.6M | $393.0K | $815.0K | $345.0K | $9.0K |
| Free Cash Flow | -$34.5M | -$86.5M | -$86.5M | -$33.8M | -$58.7M | -$93.7M | -$25.7M |
| FCF Margin | -17.1% | -58.2% | -58.2% | -33.9% | -103.8% | -268.4% | - |